tiprankstipranks
Vivendi (VIVHY)
OTHER OTC:VIVHY
Holding VIVHY?
Track your performance easily

Vivendi (VIVHY) Stock Forecast & Price Target

67 Followers
See the Price Targets and Ratings of:

VIVHY Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Vivendi
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VIVHY Stock 12 Month Forecast

There Are No Analyst Ratings for VIVHY In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

VIVHY Financial Forecast

VIVHY Earnings Forecast

Next quarter’s earnings estimate for VIVHY is $1.67 with a range of $1.67 to $1.67. The previous quarter’s EPS was -$1.63. VIVHY beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.09% of the time in the same period. In the last calendar year VIVHY has Outperformed its overall industry.
Next quarter’s earnings estimate for VIVHY is $1.67 with a range of $1.67 to $1.67. The previous quarter’s EPS was -$1.63. VIVHY beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.09% of the time in the same period. In the last calendar year VIVHY has Outperformed its overall industry.

VIVHY Sales Forecast

Next quarter’s sales forecast for VIVHY is $9.47B with a range of $9.47B to $9.47B. The previous quarter’s sales results were $6.29B. VIVHY beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 58.20% of the time in the same period. In the last calendar year VIVHY has Underperformed its overall industry.
Next quarter’s sales forecast for VIVHY is $9.47B with a range of $9.47B to $9.47B. The previous quarter’s sales results were $6.29B. VIVHY beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 58.20% of the time in the same period. In the last calendar year VIVHY has Underperformed its overall industry.

VIVHY Analyst Recommendation Trends

Rating
Dec 20
Jan 21
Feb 21
Mar 21
Apr 21
Strong Buy
0
0
0
0
0
Buy
7
7
3
2
2
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
7
4
3
3
In the current month, VIVHY has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. VIVHY average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Communication Services Sector
Find stocks in the Communication Services sector that are highly recommended by Top Performing Analysts.

VIVHY Stock Forecast FAQ

What is VIVHY’s average 12-month price target, according to analysts?
Currently, no data Available
What is VIVHY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for VIVHY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is VIVHY a Buy, Sell or Hold?
      Currently, no data Available
      What is Vivendi’s price target?
      Currently, no data Available
      What do analysts say about Vivendi?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of VIVHY?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis